Literature DB >> 3371279

Prognosis of benign childhood epilepsy with centrotemporal spikes: a follow-up study of 168 patients.

P Loiseau1, B Duché, S Cordova, J F Dartigues, S Cohadon.   

Abstract

A spontaneous and complete recovery of benign childhood epilepsy with centrotemporal or rolandic spikes (BECT) is taken for granted. However, some authors have reported the occurrence of generalized tonic-clonic seizures in a few adult patients and in some children who have seizures after a long period without problems. The aims of this study were (a) to search for early predictors of outcome and (b) to ascertain the long-term prognosis of BECT in a large group of patients. An attempt to relocate 268 patients born between 1941 and 1967 and consecutively seen as outpatients was undertaken. The outcome after age 20 is known for only 168. Being adults and cured, the others are no longer in touch with their clinics or have moved. Only one indicator of short-term prognosis was found: The earlier the onset of BECT, the longer the period with seizures. Of the 168 patients, 165 are seizure-free with follow-up ranging from 7 to 30 years. Three patients experienced generalized tonic-clonic seizures at age 18, 22-24, and 35. Two apparently had an isolated seizure. The occurrence of such seizures after recovery from BECT is a rare event (approximately 2% of cases) and a relapse with partial seizures is quite uncommon. These patients do not differ from patients remaining seizure-free.

Entities:  

Mesh:

Year:  1988        PMID: 3371279     DOI: 10.1111/j.1528-1157.1988.tb03711.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  11 in total

1.  Management of epilepsy.

Authors:  T Deonna
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

2.  The natural history of seizures and neuropsychiatric symptoms in childhood epilepsy with centrotemporal spikes (CECTS).

Authors:  Erin E Ross; Sally M Stoyell; Mark A Kramer; Anne T Berg; Catherine J Chu
Journal:  Epilepsy Behav       Date:  2019-10-20       Impact factor: 2.937

Review 3.  Diagnosis and treatment of epilepsy in children and adolescents.

Authors:  L D Morton; J M Pellock
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

Review 4.  Benign childhood partial epilepsies: benign childhood seizure susceptibility syndromes.

Authors:  C P Panayiotopoulos
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

5.  Longitudinal stability of interictal spikes in benign epilepsy with centrotemporal spikes.

Authors:  Jeffrey R Tenney; Tracy Glauser; Mekibib Altaye; Jerzy P Szaflarski; Caroline Spencer; Diego Morita; Jennifer Vannest
Journal:  Epilepsia       Date:  2016-03-25       Impact factor: 5.864

6.  Complete remission of childhood-onset epilepsy: stability and prediction over two decades.

Authors:  Anne T Berg; Karen Rychlik; Susan R Levy; Francine M Testa
Journal:  Brain       Date:  2014-10-22       Impact factor: 13.501

7.  Changes in functional organization and functional connectivity during story listening in children with benign childhood epilepsy with centro-temporal spikes.

Authors:  Jennifer Vannest; Thomas C Maloney; Jeffrey R Tenney; Jerzy P Szaflarski; Diego Morita; Anna W Byars; Mekibib Altaye; Scott K Holland; Tracy A Glauser
Journal:  Brain Lang       Date:  2017-02-13       Impact factor: 2.381

8.  Analysis of serial electroencephalographic predictors of seizure recurrence in Rolandic epilepsy.

Authors:  Hongwei Tang; Yanping Wang; Ying Hua; Jianbiao Wang; Miao Jing; Xiaoyue Hu
Journal:  Childs Nerv Syst       Date:  2019-07-02       Impact factor: 1.475

Review 9.  Critical evaluation of animal models for localization-related epilepsies.

Authors:  J Engel
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

Review 10.  Does early anti-epileptic drug treatment alter the prognosis for remission of the epilepsies?

Authors:  M O'Donoghue; J W Sander
Journal:  J R Soc Med       Date:  1996-05       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.